Hyundai Pharmaceutical Co (XKRX:004310) Interest Expense : ₩-1,977 Mil (TTM As of May. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hyundai Pharmaceutical Co's interest expense for the three months ended in May. 2024 was ₩ -502 Mil. Its interest expense for the trailing twelve months (TTM) ended in May. 2024 was ₩-1,977 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hyundai Pharmaceutical Co's Operating Income for the three months ended in May. 2024 was ₩ 1,428 Mil. Hyundai Pharmaceutical Co's Interest Expense for the three months ended in May. 2024 was ₩ -502 Mil. Hyundai Pharmaceutical Co's Interest Coverage for the quarter that ended in May. 2024 was 2.85. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hyundai Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Hyundai Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co Interest Expense Chart

Hyundai Pharmaceutical Co Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Interest Expense

Get a 7-Day Free Trial

-678.28

-614.07

-712.77

-1,160.81

-1,907.33

Hyundai Pharmaceutical Co Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Interest Expense	Get a 7-Day Free Trial															-440.19	-473.76	-514.50	-486.73	-501.60

Hyundai Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,977 Mil.

Hyundai Pharmaceutical Co (XKRX:004310) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hyundai Pharmaceutical Co's Interest Expense for the three months ended in May. 2024 was ₩-502 Mil. Its Operating Income for the three months ended in May. 2024 was ₩1,428 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in May. 2024 was ₩14,143 Mil.

Hyundai Pharmaceutical Co's Interest Coverage for the quarter that ended in May. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: May. 2024 )	/	Interest Expense (Q: May. 2024 )
	=	-1	*	1428.329	/	-501.598
	=	2.85

The higher the ratio, the stronger the company's financial strength is.

Hyundai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545

Website

http://www.hyundaipharm.co.kr

Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co Headlines

No Headlines